Back

Flow-responsive nanodisks target PTGS2 to stabilise atherosclerotic plaques

29 August 2026 (09:15 - 09:45)
Organised by: Logo
Congress Presentation Part of: Atherosclerosis and plaque biology Atherosclerosis, Cerebrovascular Diseases, Aneurysm, Restenosis ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Ms Chen Zhang

Beijing (China)

4 More presentations in this session

Presentation thumbnail
Mapping sympathetic neuroimmune interactions in atherosclerosis
Doctor M. Hong (Munich, DE)
Abstract Slides
Presentation thumbnail
Macrophages overexpressing interleukin-10 alleviate atherosclerosis by targeting the lactate-CEBPB axis to inhibit pathogenic VSMC phenotypic transitions
Doctor M. Wang (Beijing, CN)
Abstract Slides
Presentation thumbnail
Serpina3c deficiency in perivascular adipocytes impairs MAM-dependent mitochondrial calcium homeostasis and accelerates atherosclerosis
Ms G. Zhou (Nanjing, CN)
Abstract Slides
Presentation thumbnail
Single-cell transcriptomic landscape of psoriasis-accelerated atherosclerosis reveals immune remodeling and macrophage dysfunction
Doctor F. Tan (Beijing, CN)
Abstract Slides

Access the full session

Session thumbnail
Atherosclerosis and plaque biology

The Event

Event poster

ESC Congress 2026

29 August 2026 09:15 CET
You may be interested in
thumbnail
Congress Presentation
Active-target liposomal drug shows significant atherosclerotic plaque regression effect: a proof-of-concept phase 1b/2a clinical trial
1 September 2025
thumbnail
Congress Presentation
SMC-derived foam cells regulate atherosclerotic plaque stability via the crosstalk between ECM remodeling and WNT signaling
30 August 2025
thumbnail
Congress Presentation
Deficiency of myeloid prolyl hydroxylase domain proteins aggravates atherogenesis via macrophage apoptosis and paracrine fibrotic signaling
29 August 2021
thumbnail
Congress Presentation
Residual platelet activity and systemic inflammation in patients with chronic coronary syndrome in the context of aspirin monotherapy.
29 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources